Moreover, the serum levels of IL-6 and TNF-α are important parts of the Multi-Biomarker Disease Activity (MBDA) score, and both factors reflect disease activity in RA, are predictive for radiographic progression, and indicate the risk of an RA flare after a drug reduction[40, 41]. Here, TNF is linked to rheumatoid arthritis.